HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Infants born to mothers with anti-SSA/Ro autoantibodies: neonatal outcome and follow-up.

Abstract
Neonatal lupus syndrome is considered a model of passively acquired autoimmune disease. The first 10 newborns born to mothers with connective tissue disease and positive for anti-SSA/Ro antibodies enrolled in a follow-up program to evaluate the incidence of cardiac, hepatobiliary, hematologic, echoencephalographic, and cutaneous manifestations until 9 months of age are described in this study. No congenital heart block was observed, but only transient rhythm alterations were observed. In all, 1 infant showed typical neonatal lupus syndrome skin lesions at 3 months of age. During the neonatal period, echoencephalographic alterations were found more frequently, whereas at follow-up, hepatic and hematologic alterations were more often observed. In all, 1 baby showed persistent neutropenia. A standard program that enrolls all infants born to mothers with anti-SSA/Ro autoantibodies, who are at risk of developing neonatal lupus syndrome, should also include tests performed some time after birth, as a number of clinical manifestations might appear at a late stage.
AuthorsAntonio Alberto Zuppa, Annalisa Fracchiolla, Francesco Cota, Francesca Gallini, Immacolata Savarese, Vito D'Andrea, Rita Luciano, Costantino Romagnoli
JournalClinical pediatrics (Clin Pediatr (Phila)) Vol. 47 Issue 3 Pg. 231-6 (Apr 2008) ISSN: 0009-9228 [Print] United States
PMID18057159 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Antinuclear
  • SS-A antibodies
Topics
  • Antibodies, Antinuclear (blood)
  • Autoimmunity
  • Continuity of Patient Care
  • Echoencephalography
  • Exanthema (etiology)
  • Female
  • Heart Block (congenital, etiology)
  • Humans
  • Infant, Newborn
  • Male
  • Pregnancy
  • Pregnancy Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: